Paxlovid May Not Significantly Benefit Vaccinated Seniors, Study Says
New research finds that Paxlovid, a COVID-19 antiviral, had minimal benefit in vaccinated older adults.
21 Feb 21:36 · TIME
UCLA study finds no significant benefit of paxlovid for vaccinated older adults
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.
22 Feb 04:54 · News-Medical
last updated on 22 Feb 14:35